dose of ghk cu GHK-Cu Dosage Chart by Route Ghk-Cu Peptide Injection | IV
Description
Prog Brain Res 190, 145153, 10.1016/b978-0-444-53817-8.00009-8 (2011)
Injectable or oral forms are investigational and not recognized as drugs
The objective response rate in the study was 83.3% and median overall survival was 35.7 months
The complete BPC-157 research guide covers the full mechanism and general research picture
